Search results
What's Going With BioNTech Stock On Monday?
Benzinga· 1 day agoMonday, BioNTech SE BNTX reported a first-quarter EPS loss of 1.31 euros ($1.41 loss), a shift from an income of 2.05 euros, missing the consensus loss...
BioNTech Seesaws On Wide Losses, Continuing Covid Slump
Investor's Business Daily· 1 day agoSales of Comirnaty, the BioNTech-Pfizer (PFE)-partnered Covid shot, plummeted 86% to $202 million,...
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters· 1 day ago, opens new tab was widely used during the pandemic, said on Monday that almost all of its expected...
Analyst Report: BioNTech SE
Morningstar Research via Yahoo Finance· 22 hours agoBioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious ...
UPDATE 1-BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 1 day agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
BioNTech says 90% of 2024 revenues will accrue at end of year
Reuters via Yahoo Finance· 1 day agoGermany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday that almost all of its expected 2024 revenues would ...
BioNTech says 90% of 2024 revenues will accrue at end of year
WHTC 1450 Holland· 1 day agoFRANKFURT (Reuters) - Germany's BioNTech, whose COVID-19 vaccine in partnership with Pfizer was...
BioNTech Slips To Loss In Q1 On Weak Revenues, Backs FY24 View; Stock Dips In Pre-market
RTT News· 1 day agoGerman Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Monday a loss in its first quarter, compared to prior year's profit with sharply ...
BioNTech's Outlook Gives Vaccine Maker a Shot in the Arm
Investopedia· 1 day agoAmerican depositary receipts (ADRs) of BioNTech (BNTX) were down less than 1% in intraday trading...
Q1 2024 BioNTech SE Earnings Call Transcript
Guru Focus· 1 day agoThank you for joining BioNTech's First Quarter 2024 Earnings Call. As a reminder, the slides we will be using on this call and the corresponding press release published this ...